Cargando…

Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study

INTRODUCTION: Patients with end-stage kidney disease requiring maintenance haemodialysis treatment experience a dramatic cardiovascular morbidity and mortality. Due to the high atherosclerotic and arteriosclerotic burden and profound alterations in haemostasis, they frequently suffer and die from bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinecke, Holger, Jürgensmeyer, Sabine, Engelbertz, Christiane, Gerss, Joachim, Kirchhof, Paulus, Breithardt, Günter, Bauersachs, Rupert, Wanner, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144324/
https://www.ncbi.nlm.nih.gov/pubmed/30206088
http://dx.doi.org/10.1136/bmjopen-2018-022690

Ejemplares similares